Use of simeprevir following pre‐emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12‐week pilot study
暂无分享,去创建一个
M. Kurosaki | N. Izumi | K. Hasegawa | Y. Sugawara | N. Kokudo | Y. Sakamoto | T. Aoki | J. Kaneko | N. Akamatsu | Tomohiro Tanaka | S. Tamura